CYCLERION THERAPEUTICS, INC. Cash Equivalents, at Carrying Value
CYCLERION THERAPEUTICS, INC. (CYCN) had Cash Equivalents, at Carrying Value of $41.10 million as of 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Balance Sheet › Assets › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2022-05-04
- 2022-03-31: Cash Equivalents, at Carrying Value $41.10M.
- 2021-12-31: Cash Equivalents, at Carrying Value $54.00M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2022-03-31 | $41.10M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $54.00M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |